We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Champion Homes
SKY
$5.14B
| $31.8M | 0.01% |
601,274
+20,827
| +4% | +$1.21M |
|
727
Fluor
FLR
$7.96B
| $31.8M | 0.01% |
1,276,740
+107,015
| +9% | +$2.73M |
|
728
KBR
KBR
$4.8B
| $31.6M | 0.01% |
731,439
-37,020
| -5% | -$1.82M |
|
|
STOR
729
DELISTED
STORE Capital Corporation
STOR
| $31.6M | 0.01% |
1,008,783
+2,834
| +0.3% | +$80.5K |
|
730
HUB Group
HUBG
$2.92B
| $31.6M | 0.01% |
916,032
+94,168
| +11% | +$3.6M |
|
731
Fortune Brands Innovations
FBIN
$6.06B
| $31.4M | 0.01% |
685,253
+39,428
| +6% | +$2.14M |
|
732
Teradyne
TER
$59.3B
| $31.3M | 0.01% |
416,987
-15,161
| -4% | -$1.38M |
|
733
NNN REIT
NNN
$8.99B
| $31.2M | 0.01% |
782,869
+129,916
| +20% | +$5.86M |
|
|
AQUA
734
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $31.1M | 0.01% |
941,103
-236,488
| -20% | -$8.58M |
|
735
Reinsurance Group of America
RGA
$16.1B
| $31.1M | 0.01% |
247,077
-5,679
| -2% | -$698K |
|
736
Brown-Forman Class B
BF.B
$13.1B
| $31.1M | 0.01% |
466,810
+4,326
| +0.9% | +$315K |
|
737
RLJ Lodging Trust
RLJ
$1.69B
| $31.1M | 0.01% |
3,070,158
+456,694
| +17% | +$5.48M |
|
738
SL Green Realty
SLG
$3.99B
| $31M | 0.01% |
772,163
-314,549
| -29% | -$14.6M |
|
739
Fair Isaac
FICO
$22.5B
| $31M | 0.01% |
75,181
-6,001
| -7% | -$2.72M |
|
740
Axsome Therapeutics
AXSM
$10.9B
| $30.9M | 0.01% |
693,524
-77,473
| -10% | -$3.87M |
|
741
MACOM Technology Solutions
MTSI
$23.7B
| $30.8M | 0.01% |
594,190
-52,060
| -8% | -$2.85M |
|
742
Mueller Industries
MLI
$15.2B
| $30.6M | 0.01% |
2,061,412
+443,060
| +27% | +$6.89M |
|
743
Omnicell
OMCL
$1.68B
| $30.6M | 0.01% |
351,124
-11,408
| -3% | -$1.2M |
|
744
Qiagen
QGEN
$8.72B
| $30.6M | 0.01% |
697,960
+12,589
| +2% | +$622K |
|
745
Vistra
VST
$47.4B
| $30.4M | 0.01% |
1,448,266
-20,456
| -1% | -$495K |
|
746
Vontier
VNT
$4.74B
| $30.3M | 0.01% |
1,815,576
+59,329
| +3% | +$1.32M |
|
747
Toro Company
TTC
$9.49B
| $30.3M | 0.01% |
350,580
-14,652
| -4% | -$1.25M |
|
748
United Airlines
UAL
$42.1B
| $30.3M | 0.01% |
930,131
-14,511
| -2% | -$540K |
|
749
Bio-Techne
TECH
$11.3B
| $30.2M | 0.01% |
426,020
-12,656
| -3% | -$1.09M |
|
750
Vornado Realty Trust
VNO
$7.38B
| $30.2M | 0.01% |
1,304,884
-257,441
| -16% | -$7.18M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.